The Hopewell site is equipped to support clinical-stage development, process-development, and scaleup for cell and gene therapy programs.

An analysis of mpox virus genomes from individuals infected between 2018 and 2023 has provided insights into how the virus ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...